Stock listing
Genvor Incorporated
Selected listing: GNVR · OTC · USD · US
Genvor Incorporated (OTC:GNVR), Technology Services. Latest release Jul 27, 2026: Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research.
- Ticker
- OTC:GNVR
- Asset type
- Stock
- Sector
- Technology Services
- Industry
- Packaged Software
- Exchange
- OTC
- Currency
- USD
About Genvor Incorporated
Genvor Incorporated, trading under the ticker GNVR, is a public company listed in the American market. The company focuses on innovative solutions within its industry, aiming to enhance operational efficiency and drive growth. Genvor is committed to delivering value to its shareholders through strategic initiatives and a strong business model.
Latest news from Genvor Incorporated
Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
July 27, 2026
Genvor Appoints Donald Kalkofen as Chief Financial Officer
May 21, 2026
Genvor Announces Strategic Memorandum of Understanding with Canlab International(TM) to Advance Peptide Pipeline
April 17, 2026
Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline
April 14, 2026
Genvor to Present at Centri Capital Conference on April 14
April 7, 2026